(Q51916852)

English

Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.

scientific article published in April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

metabolic syndrome

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

author name string

DECODE Study Group

1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

publication date

1 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

European Journal of Cardiovascular Prevention and Rehabilitation

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

14

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

2

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

192-199

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects.

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Predictive Properties of Impaired Glucose Tolerance for Cardiovascular Risk Are Not Explained by the Development of Overt Diabetes During Follow-Up

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000230107.78524.DA

21 January 2018

Identifiers

10.1097/01.HJR.0000230107.78524.DA

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17446796

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51916852&oldid=1246124404"